David Tigtig
Family · Shenandoah, TXNPI 1114379831
Payments from drug & device makers
Across 677 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Abbott$2K
- Novartis$2K
- E.r. Squibb & Sons, L.L.C.$987
- Johnson & Johnson$822
- Boston Scientific$757
- plus $4K from 29 others
What the payments were for
- Food & beverage$12,492100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 223 | $2,320 |
| Abbott | 69 | $1,874 |
| Novartis | 115 | $1,723 |
| E.r. Squibb & Sons, L.L.C. | 48 | $987 |
| Johnson & Johnson | 33 | $822 |
| Boston Scientific | 28 | $757 |
| Merck | 30 | $660 |
| Esperion Therapeutics, Inc. | 47 | $593 |
| Bard Peripheral Vascular, Inc. | 3 | $409 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $311 |
| Boehringer Ingelheim | 5 | $297 |
| Medtronic | 4 | $209 |
| AstraZeneca | 13 | $208 |
| Scpharmaceuticals Inc. | 6 | $199 |
| Sanofi-aventis U.S. LLC | 5 | $189 |
| Edwards Lifesciences | 1 | $156 |
| Actelion Pharmaceuticals US, Inc. | 4 | $133 |
| Impulse Dynamics (USA) Inc. | 4 | $98 |
| Tactile Systems Technology Inc | 5 | $75 |
| Amarin Pharma, Inc. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $58 |
| Pfizer | 3 | $53 |
| Chiesi USA, Inc. | 3 | $42 |
| Bayer | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Cvrx, Inc. | 1 | $30 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Cashflow Solutions, LLC | 1 | $16 |
| Inari Medical, Inc. | 1 | $16 |
| Angiodynamics, Inc. | 1 | $16 |
| Cleerly, Inc. | 1 | $16 |
| Resmed Corp | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$621
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$371
- XARELTO$357
- JARDIANCE$246
- RotarexS 6 F x 135 cm$173
- Edwards SAPIEN 3 Transcatheter Heart Valve$156
- MitraClip$150
- Venclose Maven Catheter$149
- NEXLIZET$125
- NEXLETOL$125
- FUROSCIX$122
- ELIQUIS$120
- CAMZYOS$109
How this compares
$12,492 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 53 | $65,675 |
| EntrestoSacubitril/Valsartan | 26 | $38,395 |
| XareltoRivaroxaban | 15 | $21,181 |
| Ranolazine ErRanolazine | 36 | $4,142 |
| Metoprolol Succinate | 98 | $1,405 |
| Losartan Potassium | 106 | $1,318 |
| Amlodipine Besylate | 129 | $1,140 |
| Flecainide Acetate | 21 | $895 |
| Atorvastatin Calcium | 72 | $849 |
| Nifedipine ErNifedipine | 31 | $833 |
| Carvedilol | 116 | $706 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 51 | $689 |
| Ramipril | 60 | $643 |
| ClopidogrelClopidogrel Bisulfate | 75 | $636 |
| Metoprolol Tartrate | 84 | $589 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $53 | $65,67553 claims |
| NovartisEntresto | $1,723 | $38,39526 claims |
| Johnson & JohnsonXarelto | $822 | $21,18115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in Shenandoah
- Jill CampbellShenandoah$182K
- Eliza CoddShenandoah$61K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.